Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1.00%-231.12K | -129.90%-35.1K | -714.98%-385.65K | -1,117.08%-418.37K | -241.69%-254.99K | -29.01%-233.44K | 984.93%117.38K | -135.08%-47.32K | 26.31%-34.38K | 50.53%179.96K |
| Net income from continuing operations | 34.53%-124.47K | -1,487.35%-184.55K | -2,719.96%-720.92K | -222.58%-665.7K | -840.40%-438.38K | -411.08%-190.13K | 89.12%-11.63K | -62.46%-25.57K | 88.64%-206.37K | 96.28%-46.62K |
| Operating gains losses | --0 | --174.93K | --31K | -118.21%-32.85K | ---2 | ---45.16K | ---- | ---- | 426.62%180.42K | ---- |
| Unrealized gains and losses of investment securities | 93.85%-3.66K | -409.29%-166.99K | 1,100.77%179.17K | -42.41%-90K | -459.21%-66.49K | 60.72%-59.6K | -22.91%53.99K | ---17.9K | -115.20%-63.2K | -80.76%18.51K |
| Remuneration paid in stock | -102.78%-3.04K | --88.33K | --128.42K | --195.78K | --86.35K | --109.43K | --0 | --0 | --0 | --0 |
| Change In working capital | -108.31%-99.94K | -15.19%53.18K | 13.94%-3.32K | 218.40%174.41K | 491.33%163.53K | -699.77%-47.98K | 166.64%62.7K | 12.32%-3.85K | -50.21%54.78K | -17.33%27.66K |
| -Change in receivables | 155.91%3.54K | -104.22%-1.22K | 94.90%-97 | 744.57%24.73K | 571.36%4.02K | -1,480.80%-6.34K | 1,399.15%28.96K | -436.06%-1.9K | -331.01%-3.84K | 30.90%-852 |
| -Change in prepaid assets | --4.32K | --0 | ---1.82K | ---2.5K | ---2.5K | --0 | --0 | --0 | --0 | ---- |
| -Change in payables and accrued expense | -158.91%-107.8K | 61.20%54.4K | 28.37%-1.4K | 159.63%152.18K | 468.34%162.02K | -595.68%-41.64K | 31.08%33.75K | 51.73%-1.95K | -45.91%58.61K | -17.81%28.51K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1.00%-231.12K | -129.90%-35.1K | -714.98%-385.65K | -1,117.08%-418.37K | -241.69%-254.99K | -29.01%-233.44K | 984.93%117.38K | -135.08%-47.32K | 26.31%-34.38K | 50.53%179.96K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -8,185.60%-971.08K | -493.41%-1.07M | -21.33%151.39K | 169.04%12.01K | -50.05%-180.42K | ||||
| Net business purchase and sale | --0 | ---- | ---- | ---815.6K | ---815.6K | --0 | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --0 | ---- | ---- | -1,394.56%-155.48K | -41.34%-255K | -21.33%151.39K | ---- | ---- | 169.04%12.01K | -50.05%-180.42K |
| Net other investing changes | ---- | ---- | ---- | ---1 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -232.76%-172.58K | --0 | -8,185.61%-971.08K | -493.41%-1.07M | -21.33%151.39K | ---51.86K | --0 | 169.04%12.01K | -50.05%-180.42K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 72.38%138.34K | 570.38%284.3K | 789.84%418.09K | 5,810.92%1.41M | 429,526.84%1.34M | 928.18%80.25K | -555.57%-60.44K | 135.04%46.99K | 23.88K | 313 |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --8K | ---14.24K | -147.83%-3.83K | --10.07K | --8K | --0 |
| Net common stock issuance | 1.59%138.34K | --284.3K | --418.09K | --1.36M | --1.23M | --136.18K | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | 212.19%49.58K | 35,348.88%110.96K | -330.15%-41.68K | -1,174.90%-56.62K | 84.68%36.92K | --15.88K | --313 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 72.38%138.34K | 570.38%284.3K | 789.84%418.09K | 5,810.92%1.41M | 429,526.84%1.34M | 928.18%80.25K | -555.57%-60.44K | 135.04%46.99K | --23.88K | --313 |
| Net cash flow | ||||||||||
| Beginning cash position | 1,931.82%132.94K | 3,731.50%56.32K | 1,222.94%23.88K | 522.41%1.81K | 143.90%4.74K | 4,148.70%6.54K | 873.51%1.47K | 522.41%1.81K | -99.55%290 | 100.52%1.94K |
| Current changes in cash | -5,042.85%-92.78K | 1,410.33%76.62K | 9,784.78%32.44K | 1,357.03%22.07K | 13,969.57%19.14K | -200.84%-1.8K | 169,000.00%5.07K | -141.01%-335 | 102.37%1.52K | 79.68%-138 |
| End cash Position | 747.54%40.17K | 1,931.82%132.94K | 3,731.50%56.32K | 1,222.94%23.88K | 1,222.94%23.88K | 143.90%4.74K | 4,148.70%6.54K | 873.51%1.47K | 522.41%1.81K | 522.41%1.81K |
| Free cash from | 1.00%-231.12K | -129.90%-35.1K | -714.98%-385.65K | -1,117.08%-418.37K | -241.69%-254.99K | -29.01%-233.44K | 984.93%117.38K | -135.08%-47.32K | 26.31%-34.38K | 50.53%179.96K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.